Core Viewpoint - Yonghe Medical (02279) has seen a significant stock price increase, reaching a high of 2.1 HKD, marking the highest level since October of the previous year, driven by positive developments in its business and international collaborations [1] Group 1: Company Developments - Yonghe Medical's stock price rose over 18% during trading, with a current increase of 13.79% to 1.98 HKD and a trading volume of 2.2049 million HKD [1] - A delegation from the French Embassy in China visited Yonghe Medical's Beijing headquarters to experience AI scalp detection and hair care services, highlighting the company's strengths in hair transplant and care [1] - The company expressed a willingness to provide hair medical services to embassy staff, indicating potential for future collaboration [1] Group 2: Financial Performance - For the first half of the year, Yonghe Medical reported revenue of 862 million RMB and a net profit attributable to shareholders of 27.913 million RMB, marking a turnaround from previous losses [1] - As of June 30, 2025, the company operates 63 hair transplant medical institutions across 61 cities in China, making it the largest and most widely covered chain in the hair medical sector [1] - The total number of consumers served by the company reached 64,845 in the first half of the year, reflecting its operational scale and market presence [1] - CICC previously indicated that optimized store layout and refined marketing strategies have contributed to improved operational efficiency and profitability [1]
港股异动 | 雍禾医疗(02279)盘中涨超18% 门店布局优化助力盈利能力提升